Newly Approved Pill for Chronic Myeloid Leukemia Offers Greater Hope for Cure MSK experts believe that giving the targeted drug asciminib to patients with chronic myeloid leukemia at the beginning of their treatment offers them a better chance of being cured.

Experts at MSK are finding new ways to treat chronic myeloid leukemia (CML). Learn how one patient found hope of being cured after participating in a #CML clinical trial where he received a pill called #asciminib that was co-led by MSK hematologist Dr. Michael Mauro.

2024 approvals: Summary of 12 new 💊indications in heme malignancies by FDA:

1. #Zanubrutinib
2. #Ponatinib
3. #LisoCel x2
4. #Imetelstat
5. #Epcortimab
6. #Daratumuab
7. #Axatilimab
8. #Isatuximab
9. #Asciminib
10. #ObiCel
11. #Revumenib

#HemeSky #OncSky #mmsm #leusm #MedSky #lymsm